首页> 外文期刊>Rheumatology international. >Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
【24h】

Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.

机译:使用重组人可溶性凝血调节蛋白成功治疗特发性血小板减少性紫癜患者的败血症诱导的弥散性血管内凝血。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Disseminated intravascular coagulation (DIC) may complicate a variety of disorders that contribute to mortality, particularly those related to bleeding. It is therefore very difficult to manage DIC in patients with known bleeding disorders. We treated a 62-year-old woman with idiopathic thrombocytopenic purpura (ITP) complicated with sepsis-induced DIC. She had been diagnosed with ITP 8 months prior to admission. Laboratory tests showed an elevation of d-dimer and endotoxin, while pyelonephritis was shown by abdominal computed tomography. Escherichia coli was detected by blood culture. Based on these findings, the patient was diagnosed with sepsis-induced DIC due to urinary tract infection. Thrombocytopenia was refractory despite the use of antibiotics and platelet transfusion, but it was promptly improved in response to recombinant human soluble thrombomodulin (rTM). We suggest that rTM provides a new therapeutic strategy for DIC patients with high hemorrhagic risk.
机译:弥散性血管内凝血(DIC)可能会使导致死亡的各种疾病(尤其是与出血有关的疾病)复杂化。因此,在患有已知出血性疾病的患者中,很难控制DIC。我们治疗了患有特发性血小板减少性紫癜(ITP)并伴有败血症诱导的DIC的62岁女性。入院前8个月,她被诊断出患有ITP。实验室检查显示d-二聚体和内毒素升高,而腹部CT检查显示肾盂肾炎。通过血液培养检测到大肠杆菌。基于这些发现,该患者被诊断为尿路感染引起败血症诱导的DIC。尽管使用了抗生素和血小板输注,血小板减少症仍然是难治性的,但对重组人可溶性血小板调节蛋白(rTM)的反应迅速改善了血小板减少症。我们建议rTM为具有高出血风险的DIC患者提供一种新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号